The total results for all efficacy measures considered and the results of subgroup analyses according to the class of the drugs are shown in Table 2
For example, selonsertib (GS-4997) is a highly selective and potent ASK1 inhibitor with potential anti-inflammatory, anti-tumour, and anti-fibrotic activities 40
However, there is a need for further studies to confirm our results and explore the mechanisms of GLP-1 RAs, cirrhotic decompensation and hepatic encephalopathy." The study's limitations were a lack of complete information on family history, body weight, diet, physical activity, biochemical tests, pathology, haemoglobin A1C, and imaging findings that could affect the results
2.0mg weekly (8mg total per vial)